Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT05124639

Clinical Trial of a Group Self-management Support Program for Anxiety Disorders

Background. Self-management support is a complementary approach to treatment that aims to educate participants on the nature of anxiety and to improve their strategies to manage symptoms and well-being, thus presenting the potential to enhance recovery, improve outcomes, reduce recurrence rates and lower health care costs. There is limited evidence to support the effectiveness of group self-management support for anxiety disorders in community-based care.

Objectives. This study aims at examining the effectiveness of a virtual group self-management support program (SMS) for anxiety disorders as an add-on to treatment-as-usual (TAU) in community-based care settings. We will also assess the incremental cost/effectiveness ratio and the implementability of the intervention.

Methods. The trial is a pragmatic randomized controlled trial with a pre-treatment, post-treatment (4-month post-randomization), and follow-ups at 8, 12 and 24-months. Intervention. The experimental condition will consist of a 10-week SMS program for anxiety disorders in addition to TAU. The control condition will receive TAU without restrictions for anxiety disorders. Inclusion criteria will comprise being 18 years old or older, French-speaking, and presenting symptoms of anxiety disorders based on self-reported validated assessment scales. Patients will be recruited in the province of Quebec (Canada). Outcome measures: The primary outcome measure is the Beck Anxiety Inventory (BAI). The secondary outcome measures include self-reported instruments for anxiety and depressive symptoms, recovery, self-management, quality of life, and service utilisation. Statistical analysis: Intention-to-treat analysis. A mixed effects regression model will be used to account for between and within-subject variations in the analysis of the longitudinal effects of the intervention.

Expected outcomes. The rigorous evaluation of the SMS intervention in the real world will provide information to decision makers, health care managers, clinicians and patients regarding the added value of group SMS for patients with anxiety disorders. Widespread implementation of this intervention could lead to more efficient mental health care services, to better long-term outcomes and to a significant reduction in the extensive social and economic burden of anxiety disorders.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Université de Sherbrooke

Sherbrooke, Quebec, J1H 5N4, Canada

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • (1) aged 18 and over,
  • (2) fluent in spoken and written French,
  • (3) presence of symptoms of anxiety disorders based on self-reported validated assessment scales and semi-structured assessment interview,
  • (4) access to a computer or tablet connected to the internet with microphone and video camera

Exclusion criteria

  • (1) previous enrolment in the SMS intervention provided by Relief
  • (2) active suicidal intentions,
  • (3) severe depressive symptoms,
  • (4) active substance-related and addictive disorder,
  • (5) cognitive impairment

Treatment and study plan

Group self-management support program for anxiety disorders

Behavioral

The group SMS manualized program for anxiety disorders (https://monrelief.ca) aims at improving self-management capabilities through weekly 2.5-hours sessions with 10-15 patients over a 10-week period.This trial will focus solely on the virtual format of the program. The SMS program covers the following themes: getting to know your anxiety; building self-awareness; reconsidering your lifestyle habits; adopting a problem-solving method; avoidance and exposure; acceptance and committed action; seeing things differently; managing your emotions; receiving support from others; and consolidating your toolkit.

Other names: SMS+TAU

Primary outcomes

  1. Change in Beck Anxiety Inventory (BAI)

    Time frame: Baseline and post-treatment (4-month post-randomization)

Secondary outcomes

  1. Change in Beck Anxiety Inventory

    Time frame: Baseline, post-treatment, and 8-month, 12-month, 24-month post-randomization follow-ups

  2. Change in Generalised Anxiety Disorder-7

    Time frame: Baseline, post-treatment, and 8-month, 12-month, 24-month post-randomization follow-ups

  3. Change in Patient Health Questionnaire-9

    Time frame: Baseline, post-treatment,12-month and 24-month post-randomization follow-ups

  4. Change in Recovery Assessment Scale - Revised

    Time frame: Baseline, post-treatment,12-month and 24-month post-randomization follow-ups

  5. Change in Mental Health Self-Management Questionnaire

    Time frame: Baseline, post-treatment,12-month and 24-month post-randomization follow-ups

  6. Change in Assessment of Quality of Life - 6 Dimensions

    Time frame: Baseline, post-treatment, and 8-month, 12-month, 24-month post-randomization follow-ups

  7. Change in Health care use and indirect costs

    Time frame: Baseline, post-treatment, and 8-month, 12-month, 24-month post-randomization follow-ups

    Health care costs for other mental health consultations (e.g. type of professional, duration, costs), psychotherapy experience (including CBT) and psychotropic medication.

  8. Change in Administrative databases records

    Time frame: Starting 12 months prior to participant enrolment up to the 24-month post-randomization follow-up

    Data will be obtained from provincial administrative databases for medical and biopsychosocial services, hospitalization's registry, and medication data.

Other outcomes

  1. Gross Cohesion Scale

    Time frame: During the 10-week SMS program, after sessions 3 and 8 (for experimental arm participants)

  2. Working Alliance Inventory

    Time frame: During the 10-week SMS program, after sessions 3 and 8 (for experimental arm participants)

Sponsors and collaborators

Lead sponsor

Université de Sherbrooke

Other

Collaborators

  • Canadian Institutes of Health Research (CIHR)
  • Relief

Registry information

Official study title

A Pragmatic Randomized Controlled Trial of a Group Self-management Support Program Versus Treatment-as-usual for Anxiety Disorders

Important dates

Study start
2022
Primary completion
2024
Study completion
2026
First posted
Nov 18, 2021
Registry last updated
May 9, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.